133 related articles for article (PubMed ID: 37827527)
1. An evaluation of naloxone transit for opioid overdose using drones: A case study using real-world coroner data.
Royall PG; Courtney P; Goodair C; Copeland CS
Addiction; 2024 Feb; 119(2):379-385. PubMed ID: 37827527
[TBL] [Abstract][Full Text] [Related]
2. Optimizing a Drone Network to Respond to Opioid Overdoses.
Cox DJ; Ye JJ; Zhang C; Van Vleet L; Nickenig Vissoci JR; Buckland DM
West J Emerg Med; 2023 Sep; 24(5):823-830. PubMed ID: 37788021
[No Abstract] [Full Text] [Related]
3. Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.
McAuley A; Bouttell J; Barnsdale L; Mackay D; Lewsey J; Hunter C; Robinson M
Addiction; 2017 Feb; 112(2):301-308. PubMed ID: 27614084
[TBL] [Abstract][Full Text] [Related]
4. Ineffectiveness of Paramedic Naloxone Administration as a Standalone Metric for Community Opioid Overdoses and the Increasing Use of Naloxone by Community Members.
Chris Smith J; Burr WS
Prehosp Emerg Care; 2023; 27(3):328-333. PubMed ID: 35073227
[TBL] [Abstract][Full Text] [Related]
5. Circumstances surrounding non-fatal opioid overdoses attended by ambulance services.
Madah-Amiri D; Clausen T; Myrmel L; Brattebø G; Lobmaier P
Drug Alcohol Rev; 2017 May; 36(3):288-294. PubMed ID: 28036135
[TBL] [Abstract][Full Text] [Related]
6. Designing a public access naloxone program for public transportation stations.
Kohli S; Garg J; Velasquez DE; Weiner SG
Healthc (Amst); 2023 Jun; 11(2):100694. PubMed ID: 37247465
[TBL] [Abstract][Full Text] [Related]
7. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
[TBL] [Abstract][Full Text] [Related]
8. Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021.
Rock P; Slavova S; Westgate PM; Nakamura A; Walsh SL
Drug Alcohol Depend; 2024 Feb; 255():111062. PubMed ID: 38157702
[TBL] [Abstract][Full Text] [Related]
9. [Fatal opioid overdoses usually occur without anyone being present and able to intervene. Knowledge of the presence of witnesses is important for how naloxone programs should be designed].
Andersson L; Johnson B
Lakartidningen; 2022 Jan; 119():. PubMed ID: 35077567
[TBL] [Abstract][Full Text] [Related]
10. The effect of untargeted naloxone distribution on opioid overdose outcomes.
Dowd WN
Health Econ; 2023 Dec; 32(12):2801-2818. PubMed ID: 37670413
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdoses.
Edvardsen HME; Aamodt C; Bogstrand ST; Krajci P; Vindenes V; Rognli EB
Br J Clin Pharmacol; 2022 Oct; 88(10):4494-4504. PubMed ID: 35470456
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
13. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
14. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
15. EMS runs for suspected opioid overdose: implications for surveillance and prevention.
Knowlton A; Weir BW; Hazzard F; Olsen Y; McWilliams J; Fields J; Gaasch W
Prehosp Emerg Care; 2013; 17(3):317-29. PubMed ID: 23734988
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose.
Goldberg SA; Dworkis DA; Liao VT; Eyre AJ; Albert J; Fawcett MM; Narovec CM; DiClemente J; Weiner SG
Prehosp Emerg Care; 2018; 22(6):788-794. PubMed ID: 29723076
[TBL] [Abstract][Full Text] [Related]
17. Real-world study of multiple naloxone administrations for opioid overdose reversal among emergency medical service providers.
Abdelal R; Banerjee AR; Carlberg-Racich S; Cebollero C; Darwaza N; Kim C; Ito D; Epstein J
Subst Abus; 2022; 43(1):1075-1084. PubMed ID: 35442869
[No Abstract] [Full Text] [Related]
18. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
19. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
[TBL] [Abstract][Full Text] [Related]
20. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
